Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest tumour Stories

2009-07-21 20:20:00

In the new issue of the Developmental Cell journal, a team of scientists at Singapore's Agency for Science, Technology and Research (A*STAR) and the University of North Carolina School of Medicine at Chapel Hill, report research findings about the molecular mechanisms behind the aging process, which has up till now been poorly understood, that offer the possibility that a novel, pharmacological approach could be developed to combat age-related disorders.In their research with lab rodents, the...

2009-06-11 08:13:37

Eureka! Vancouver scientists from the Ovarian Cancer Research (OvCaRe) Program at BC Cancer Agency and Vancouver Coastal Health Research Institute have discovered that there appears to be a single spelling mistake in the genetic code of granulosa cell tumours, a rare and often untreatable form of ovarian cancer. This means that out of the three billion nucleotide pairs that make up the genetic code of the tumour, one "“ the same one in every tumour sample "“ is incorrect. The...

2009-06-10 10:42:03

Hormone therapy has serious side effects and is therefore used only when the tumour has grown too large to be treated in any other way, or when the tumour has spread and formed metastases. The hormone that is given causes the natural production of male sex hormone to fall, and the tumour stops growing. Pain also usually decreases."Our results suggest that the tumour properties change following hormone therapy such that the tumours at a later stage can continue to grow and spread in the body....

2009-05-08 00:00:00

FRIMLEY, England, May 8 /PRNewswire/ -- - Glivec(R) (imatinib) Now Approved in the UK for Post-Surgery Treatment of Patients With KIT (CD117)-Positive Gastrointestinal Stromal Tumours (GIST), who are at Significant Risk of the Cancer Returning After Surgery(1) - Use of Glivec(R) After Surgery Significantly Reduces Risk of Cancer Relapse(2) - If Untreated After Surgery, 50% of patients Will Experience Their Cancer Returning Within Two Years(3,4) Glivec(R) has been...

2009-02-12 08:50:11

Montreal, February 11th, 2009 - The development of cancerous tumours is highly dependent on the nutrients the tumours receive through the blood. The team of Dr. Janusz Rak, of the Research Institute of the McGill University Health Centre (MUHC) at the Montreal Children's Hospital, including Dr. Khalid Al-Nedawi and Brian Meehan, has just discovered a new mechanism that tumours use to stimulate the growth of the blood vessels that feed them. The researchers have also proposed a new way to...

2009-01-13 11:54:30

Researcher Kristina Djanashvili has developed a substance that enables doctors to get better MRI scans of tumours. On Tuesday 13 January, Djanashvili will be awarded a doctorate by TU Delft for her work in this field.The medical profession's ability to trace and visualise tumours is increasing all the time. Detection and imaging techniques have improved enormously in recent years. One of the techniques that have come on by leaps and bounds is MRI. Patients who are going to have MRI scans are...

2008-10-23 06:00:12

NERVIANO, Italy, October 23 /PRNewswire/ -- - First Responses in Solid Tumours Reported. Aurora inhibitors play a key role in cell duplication and are implicated in both the onset and progression of numerous types of tumour. A lecture focusing on Aurora kinase inhibitors will be presented today by Dr. Bernard Laffranchi during the 20th EORTC-NCI-AACR Symposium "Molecular Targets and Cancer Therapeutics" organised from 21st to 24th October 2008 in Geneva. Dr Laffranchi, Director Clinical...

2008-09-06 21:00:04

Many breast cancers are made worse by the hormone oestrogen and women take drugs known as aromatase inhibitors to reduce the oestrogen in their body and restrict the cancer's progress. But eventually the tumour becomes resistant to this treatment and starts to grow.Now American researchers said a drug called sorafenib may be able to reverse this process."At first, the tumour's growth is halted because the aromatase inhibitor is depriving the cancer of the oestrogen it needs to grow," says...

2008-09-01 03:00:15

GENEVA, Sept. 1 /PRNewswire/ -- Chrigu from Switzerland has been awarded the Grand Prize in the first ever Reel Lives: Cancer Chronicles Film Festival at a ceremony in Geneva, Switzerland. Runners up prizes were also awarded to The Truth About Cancer (USA) for Best Reportage, The Art of Living (India) for Best Personal Story, The Children of Avenir (Morocco) for Best Organizational Film and Hookah (Israel) for the best Public Service Announcement. Award winners were chosen from an...

2008-08-29 03:00:19

By Chotel, F Unnithan, A; Chandrasekar, C R; Parot, R; Jeys, L; Grimer, R J We have analysed the pattern of symptoms in patients presenting with synovial sarcoma to identify factors which led to long delays in diagnosis. In 35 children, the early symptoms and the results of clinical and radiological investigation were reviewed, along with the presumed diagnoses. The duration of symptoms was separated into patient delay and doctor delay. Only half of the patients had one or more of the four...